LON:ABC Abcam (ABC) Share Price, News & Analysis → AI Bubble Now at Critical Mass (From Porter & Company) (Ad) Free ABC Stock Alerts GBX 1,226 +123.00 (+11.15%) (As of 12/13/2022) Add Compare Share Share Today's Range 1,115▼ 1,25950-Day Range 1,226▼ 1,22652-Week Range 1,013.57▼ 1,760Volume6.37 million shsAverage Volume392,791 shsMarket Capitalization£2.81 billionP/E Ratio20,433.33Dividend Yield0.91%Price TargetN/A Stock AnalysisStock Analysis Get Abcam alerts: Email Address Ad Huge AlertsTrending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! Click To Get Our Next Alert About Abcam Stock (LON:ABC)Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.Read More ABC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABC Stock News HeadlinesMarch 27, 2024 | finanznachrichten.deCell Culture Market Worth $57.9 billion | MarketsandMarketsMarch 25, 2024 | uk.finance.yahoo.comGlobal Research Antibodies Market Projected to Reach $5.5 Billion by 2030, Driven by Advances in Personalized MedicineMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMarch 20, 2024 | americanbankingnews.comAbcam (LON:ABC) Stock Crosses Below Two Hundred Day Moving Average of $1,226.00March 18, 2024 | sg.finance.yahoo.comSuper Micro Computer, Deckers Outdoor make S&P 500 debutFebruary 25, 2024 | msn.comBill Gates' 16 Dividend Stocks To BuyFebruary 21, 2024 | uk.finance.yahoo.com3D Cell Cultures Market 2024-2028: Global Demand for 3D Cell Culture Solutions Surges with Expanding Biotechnology ApplicationsFebruary 19, 2024 | msn.comWhy science parks are importantMarch 28, 2024 | Huge Alerts (Ad)Trending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! February 14, 2024 | finance.yahoo.comDanaher Corporation: Reaffirming BUY, raising target to $285February 5, 2024 | finanznachrichten.deRecombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets.February 5, 2024 | uk.finance.yahoo.comDanaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug DevelopmentFebruary 3, 2024 | seekingalpha.comDanaher: Better Positioned For The FutureFebruary 2, 2024 | finance.yahoo.comTop Stock Reports for Eli Lilly, Danaher & CitigroupFebruary 1, 2024 | finanznachrichten.deLazard Reports Fourth-Quarter and Full-Year 2023 ResultsJanuary 30, 2024 | finanznachrichten.deDanaher Corporation: Danaher Reports Fourth Quarter and Full Year 2023 ResultsJanuary 30, 2024 | reuters.comDanaher forecasts revenue decline in 2024, shares fallJanuary 29, 2024 | msn.comAnother UK snub: Cambridge spin-out eyes New York IPO as unicorn status beckonsJanuary 26, 2024 | bizjournals.comHere's how a bite-sized merger deal between two Reston-based contractors benefitted bothJanuary 23, 2024 | finance.yahoo.comResearch Antibodies Global Market Analysis to 2030: Focus on Monoclonal Antibodies, Rising Demand in North America, Strategies of Leading PlayersJanuary 23, 2024 | ca.finance.yahoo.comDHR Sep 2024 210.000 callJanuary 19, 2024 | finance.yahoo.comDanaher Corporation (DHR) Completed the Acquisition of AbcamJanuary 14, 2024 | uk.finance.yahoo.comAbcam PLC (A8C3.MU)January 9, 2024 | finanznachrichten.deDanaher Corporation: Danaher CEO to Comment on Financial PerformanceJanuary 9, 2024 | msn.comDanaher gives Q4 guidance, expects low double-digit drop in revenueJanuary 8, 2024 | finance.yahoo.comMesa Laboratories Appoints Mark Capone to its Board of DirectorsDecember 27, 2023 | seekingalpha.comMy Top 2024 Stock Pick: DanaherSee More Headlines Receive ABC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:ABC CUSIPN/A CIKN/A Webwww.abcam.com Phone+44-1223-696000FaxN/AEmployees1,650Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio20,433.33 Forward P/E Ratio33.28 P/E Growth1.57Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio31.60 Current Ratio1.27 Quick Ratio0.89 Sales & Book Value Annual Sales£350.40 million Price / Sales8.02 Cash FlowGBX 50.93 per share Price / Cash Flow24.07 Book ValueGBX 318.30 per share Price / Book3.85Miscellaneous Outstanding Shares229,272,000Free FloatN/AMarket Cap£2.81 billion OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Alan Thomas Hirzel BS (Age 54)M.B.A., M.S., MBA, MS, CEO & Exec. Director Comp: $1.23MMr. Michael Shaun Baldock B.A. (Age 58)CFO & Director Comp: $881.14kMr. Mark DermodyInterim CIOJames StaveleyVP of Investor RelationsMarc PerkinsGen. Counsel & Company Sec.Emma SceatsSr. VP of Sales, Service & Bus. Devel.Mr. Nick SkinnerSr. VP of HRMr. Mark BushfieldSr. VP of Research & InnovationMs. Kirstie Speck BBusScHead of Consumer InsightsMs. Yvonne ChienSr. VP of Customer ExperienceMore ExecutivesKey CompetitorsBTGLON:BTGGenusLON:GNSOxford Nanopore TechnologiesLON:ONTUDG HealthcareLON:UDGIndiviorLON:INDVView All Competitors ABC Stock Analysis - Frequently Asked Questions How have ABC shares performed in 2024? Abcam's stock was trading at GBX 1,226 at the start of the year. Since then, ABC shares have increased by 0.0% and is now trading at GBX 1,226. View the best growth stocks for 2024 here. What other stocks do shareholders of Abcam own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA). How do I buy shares of Abcam? Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:ABC) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeAI to Meet the Same Fate as EVs? Porter & CompanyGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.